Michelle Higgin, PhD
Managing Principal
PharmaDirections
Michelle is a versatile development & regulatory strategist in all phases of drug development.
She has been a pioneer in the virtual biotech model for the past 20 years and has successfully guided over 60 new drugs (all modalities) into the clinic in US, Europe, and Australia in all major therapeutic categories (CNS, rare, oncology, GI and metabolic).
Her primary competencies are in tactical strategic development and translational sciences: taking therapeutic concepts from scientific infancy to a tactical clinical development and business model that is fundable and tractable.
She has played C-level leadership roles in a number of biotech companies including but not limited to: Cavion (now Jazz), Cortendo (now Xeris), ZielBio and has founded and funded several emerging biotech companies (Slate Bio, GenEp Bio and Cypress Biopharma).